National Comprehensive Cancer Network



About NCCN

Cancer- and Chemotherapy-Induced Anemia Panel - Disclosures as of 5/26/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Morey Blinder, MD

None

None

None

None

4/30/2013

David Cella, PhD

None

None

None

None

2/8/2013

Charles Cleeland, PhD

None

None

None

None

9/13/2012

Peter F. Coccia, MD

None

None

None

None

12/21/2012

Benjamin Djulbegovic, MD, PhD

None

None

None

None

3/27/2013

Mary Dwyer, MS

None

None

None

None

3/26/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Jeffrey A. Gilreath, PharmD

None

None

None

None

3/27/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Maria Ho, PhD

None

None

None

None

8/3/2012

Eric H. Kraut, MD

Pieris

pieris

None

None

4/23/2013

Marisa B. Marques, MD

None

None

None

None

4/4/2013

Ursula A. Matulonis, MD

AstraZeneca Pharmaceuticals LP;
Bristol-Myers Squibb Company;
Eli Lilly and Company;
Genentech, Inc.;
Merck & Co., Inc.

Clovis;
Pathway Therapeutics

None

None

7/3/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

Michael M. Millenson, MD, FACP

None

None

None

None

2/22/2013

Denise Reinke, MS, NP

None

None

None

None

3/20/2012

George M. Rodgers III, MD, PhD

None

None

None

None

2/7/2013

Joseph Rosenthal, MD

None

None

None

None

2/5/2013

Satish Shanbhag, MBBS, MPH

None

None

None

None

3/12/2013

Gerald Soff, MD

None

None

None

None

10/3/2012

Richard S. Stein, MD

None

None

None

None

4/16/2012

Gordana Vlahovic, MD

None

None

None

None

8/30/2012

Alva B. Weir III, MD

None

None

None

None

3/29/2013